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SUMMARY
Introduction Cryoglobulins are single or mixed immunoglobulins that are subject to reversible precipi-
tation at low temperatures.
Objective The aims of this paper were: 1. Comparison of cryoglobulin positive (CP), cryoglobulin nega-
tive (CN) heroin addicts and the control group (CG) in terms of serum immunoglobulins IgG, IgA and 
IgM and complement components C3 and C4; 2. Comparison of CP and CN heroin addicts in terms of 
rheumatoid factor (RF) and circulating immune complexes (CIC); 3. Assessment of clinical manifestations 
in CP heroin addicts.
Methods This is a comparative study of cases (outpatients) treated at the University Clinic of Toxicology 
in Skopje over 3.5 years, from January 2009 to June 2012. In this study 140 heroin addicts without HbsAg 
were examined, seronegative for HCV and HIV infections. They were divided into 2 groups: 70 CP and 70 
CN heroin addicts. A previously designed self-administered questionnaire was used as a data source on 
participants. All heroin addicts underwent the following analyses: urea and creatinine in serum; creati-
nine in urine; proteinuria; 24-hour proteinuria; IgM, IgG, IgA, C3, C4 ; RF; CIC; creatinine clearance; ECG; 
toxicological analyses for opioids in a urine sample; cryoglobulins. In addition to these 2 groups, IgG, 
IgA, IgM, C3 and C4 were also examined in 70 healthy subjects (CG).
Results The study showed that there was no statistically significant difference between CP, CN heroin ad-
dicts and CG regarding the concentration of IgA, IgG, IgM, C3 and C4, and between CP and CN regarding 
the concentration of CIC. There was significant difference between CP and CN regarding the concentra-
tion of RF. The following conditions were significantly more frequently manifested in CP than in CN heroin 
addicts: arthralgia, Raynaud’s phenomenon, respiratory difficulties, neurological disorders, manifested 
skin changes, hematuria, 24-hour proteinuria levels, and decreased renal clearance.
Conclusion There were no differences in concentrations of IgG, IgA, IgM, C3, C4 and CIC, while there was 
a difference in concentration of RF between CP and CN heroin addicts. Clinical manifestations (arthralgias, 
Raynaud’s phenomenon, respiratory, neurologic, renal disorders and skin changes) were more common 
in CP heroin addicts.
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INTRODUCTION
Effects of heroin on the immune system may be 
in the form of immunosuppression (frequent 
infections and neoplasms) and in the form of 
immunostimulation (hypersensitivity and au-
toimmune reaction) [1, 2]. Conducted studies 
have demonstrated that heroin and its diluents 
might cause structural and antigen changes 
in numerous tissues and organs followed by 
development of autoimmune reactions (pro-
duction of antibodies and creation of immune 
complexes) [3]. The incidence of autoantibod-
ies and the severity of clinical symptoms are 
related to the duration of drug abuse, and the 
titre of autoantibodies is not always related to 
the presence of HIV infection or a chronic viral 
infection. The titre of autoantibodies decreases 
after cessation of heroin abuse [4].
Cryoglobulins are single or mixed immu-
noglobulins that are subject to reversible pre-
cipitation at low temperatures. Cryoglobulins 
precipitate or are transformed into sludge and 
at low temperatures may result in hyperviscos-
ity leading to obstruction of small and medi-
um size blood vessels in the human body [5]. 
Cryoglobulinemia is a chronic autoimmune 
disease, which is associated with hepatitis C 
infection in most cases [6]. Essential mixed cry-
oglobulinemia (MC) is a condition that occurs 
when the cryoglobulin proteins are a mixture 
of various antibody types forming for unknown 
reasons. It is a rare autoimmune disease. Cry-
oglobulins may or may not cause some diseases. 
They can accompany another condition or be 
an isolated condition themselves. Problems 
arise from the abnormal thickness of the blood 
and inflammation of blood vessels resulting 
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in conditions such as vasculitis. It can cause blockage of 
blood vessels leading to organ damage [7]. MC may induce 
systemic vasculitis and it has been reported that patients 
with non-HCV-related cryoglobulinemia vasculitis had 
an increased risk of developing B-cell non-Hodgkin’s lym-
phoma [8]. Typical presentations of cryoglobulinemia are 
the following: cutaneous manifestations that appear on the 
lower extremities including maculae, purpuric papules and 
ulcerations; arthralgias, myalgias; renal disorders presented 
with clinically isolated proteinuria and hematuria that are 
more common than nephrotic syndrome, nephritic syn-
drome or acute renal failure. The condition may also be 
associated with hypertension; pulmonary failure – pres-
ence of interstitial infiltrates shown by chest x-ray; neu-
rological manifestations – neuropathy determined with 
electromyography might appear in 70–80% of patients 
with cryoglobulinemia; changes in sensory nerve fibers are 
more common than in motor fibers, with pure motor neu-
ropathy in approximately 5% of patients; abdominal pain; 
acrocyanosis; Meltzer triad (purpura, arthralgia, and weak-
ness) [9, 10]. Laboratory analyses that were conducted are: 
evaluation of serum cryoglobulins, biochemical analysis of 
urine, a complete blood count, rheumatoid factor, evalua-
tion of the complement (hypocomplementemia, especially 
of C4 component). The most important laboratory indi-
cators are immune complexes by rheumatoid factor and 
polyclonal IgG immunoglobulin [9]. The most important 
laboratory indicators are immune complexes by rheuma-
toid factor (RF) and polyclonal IgG immunoglobulin. RF 
is an autoantibody that is bound to Fc region of IgG [11]. 
Cryoglobulins may occur alone, may be accompanied by 
clinical symptomatology (classical) and may occur as clini-
cal manifestations of cryoglobulinemia without presence of 
cryoglobulins in serum [12].
OBJECTIVE
The aims of this study were: 1. Comparison of cryoglobu-
lin positive (CP), cryoglobulin negative (CN) heroin ad-
dicts and the control group (CG) in terms of serum immu-
noglobulins IgG, IgA, IgM and complement components 
C3 and C4; 2. Comparison of CP and CN heroin addicts in 
terms of RF and circulating immune complexes (CIC); 3. 
Assessment of clinical manifestations in CP heroin addicts.
METHODS
This is a comparative study of cases (outpatients) treated 
at the University Clinic of Toxicology in Skopje over 3.5 
years, from January 2009 to June 2012. In this study 140 
heroin addicts without HbsAg were examined, seronega-
tive for HCV and HIV infections. They were divided into 
two groups: 70 CP and 70 CN heroin addicts. In addi-
tion to these 2 groups, immunoglobulins and comple-
ment fractions C3, C4 were examined in 70 healthy sub-
jects (i.e. CG). A previously designed self-administered 
questionnaire was used as a data source on participants. 
The following instruments were used for testing: Cobas-
Integra 700/Roche (urea, creatinine in serum; creatinine 
in urine; proteinuria; quantitative determination of im-
munoglobulins: IgM, IgG, IgA; complement C3, C4; RF); 
spectrophotometer (i.e. CIC); creatinine clearance (eCCr) 
calculated by Cockcroft-Gault formula; 24-hour proteinu-
ria calculated by Uprot/Ucreat formula; 12-channel ECG 
examination by Schiller; toxicological analyses for opioids 
in urine samples (FPIA); cryoglobulin: qualitative method 
according to a reference method, at the Institute of Trans-
fusion Medicine, Skopje. All tests were performed at the 
Institutes of Clinical Biochemistry, Forensic Medicine and 
Transfusion Medicine in Skopje. Subjects participating in 
this study gave written informed consent.
A statistical program SPSS for Windows, version 13.0, 
was used for statistical data processing. The following sta-
tistical methods were used: descriptive methods, to test the 
significance of difference; chi-square test, t-test for inde-
pendent samples, analyses of variance. The initial level of 
statistical significance was established at p<0.05.
RESULTS
Detectable cryoglobulins were found in 70 (19.3%) of 363 
anti-HCV seronegative heroin addicts. In order to analyze 
clinical manifestations of cryoglobulinemia, 70 CP heroin 
addicts were compared with a group of 70 CN heroin ad-
dicts and 70 healthy subjects in the CG adjusted for gender 
and age. CP and CN heroin addicts were homogeneous in 
relation to the gender: CP male/female (55/15 cases) versus 
CN (53/17 cases), chi-square=0.16, p=0.69. There was a sig-
nificant difference in mean age between CP and CN heroin 
addicts (30.15±5.29 vs 26.54±5.39), p=0.0001. Cryoglobu-
lin was more frequently detected in intravenous heroin ad-
dicts as compared to participants who inhaled (54 vs 16), 
p=0.0001. Presence of cryoglobulins was also affected by the 
duration of heroin abuse (drug addicts that reported longer 
period of heroin abuse had more often detectable cryoglob-
ulins). Regarding the length of heroin addiction there were 
3 groups of CP vs CN heroin addicts: 0–3 years (4 vs 24), 
4–7 years (12 vs 22), and the majority of CP heroin addicts 
were using heroin for more than 7 years (54 vs 22 cases).
Analysis of variance showed that there was no signifi-
cant difference between CP, CN heroin addicts and CG in 
the concentration of IgA, IgG and IgM (Table 1).
The same applies to differences between the 3 groups 
in the concentrations of complement fractions. Analysis 
of variance showed that there was no significant difference 
between CP, CN heroin addicts and CG in concentration 
of complement fractions C3 and C4 (Table 2).
T-test for independent samples showed that there was 
statistically significant difference between CP and CN her-
oin addicts in concentration of RF, p=0.0019. RF positivity 
(above ref. values 13 IU/ml) was more frequent in CP than 
in CN (25 vs 7 cases) (Table 3).
T-test for independent samples showed that there was 
no significant difference between CP and CN heroin ad-
dicts in concentration of CIC, p=0.68.
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The following conditions were significantly more fre-
quently manifested in CP than in CN heroin addicts:
1. Arthralgia (37 vs 22, chi-square=6.59, p=0.01). This 
symptom was mainly located at interphalangeal and meta-
carpophalangeal joints of hands;
2. Raynaud’s phenomenon (24 vs 3, chi-square=20.24, 
p=0.00001). In all CP heroin addicts with Raynaud’s phe-
nomenon discoloration of the skin on the hands (pallor 
and cyanosis) was registered. In several cases more chang-
es, like discoloration of the skin on toes (2 cases), ears (6 
cases), nose (3 cases), burning sensations of the hands (17 
cases), were registered. All patients gave information that 
these changes are more intense at lower temperatures. In 
CN heroin addicts the discoloration of the skin on the 
hands was registered;
3. Respiratory difficulties: shortness of breath, cough 
(17 vs 4, chi-square=9.05, p=0.0026). Twelve of CP pa-
tients had positive lung physical findings (tiny wet litter 
bilateral basal). The chest X-ray was performed on all the 
CP and CN patients with respiratory difficulties and in-
terstitial infiltrate was found in only 6 CP patients. Gas 
analyses were performed in all CP and CN patients with 
respiratory difficulties, but partial respiratory insufficiency 
was determined in only two CP patients;
4. Neurological disorders: paresthesias and decreased 
sensibility of lower limbs (16 vs 2, chi-square=12.5, 
p=0.0004). All patients were examined by a neurologist. 
Electromyography (EMG) was recommended to all pa-
tients with neurological disorders. This method was re-
jected by 7 CP and 2 CN patients. Nine CP alone under-
went EMG, and six of them had a positive EMG finding (5 
with distal symmetric sensor neuropathy and only 1 with 
sensory-motor neuropathy in the lower limbs);
5. Manifested skin changes (15 vs 2, chi-square=11.32, 
p=0.00077). All patients with skin changes were exam-
ined by a dermatologist. The changes were localized in the 
lower limbs. The most common change was purpura (CP 
13 cases, CN 2 cases), one CP case with erythema and one 
CP case with ulcer;
6. Hematuria (8 vs 2, chi-square=3.88, p=0.049);
7. 24-hour proteinuria levels (25 vs 10, chi-square=8.57, 
p=0.0034);
8. Decreased renal clearance (22 vs 15, p=0.000023).
There were no significant differences between the ex-
amined groups regarding cardiological manifestations (4 
vs 1, chi-square=0.89, p=0.35).
DISCUSSION
In the majority of cases cryoglobulinemia (cold antibody 
in the blood) manifestation is associated with hepatitis C 
virus infection, but etiology of cryoglobulinemia is not 
always known [6, 13]. Considering the fact that HCV has 
an extremely low prevalence in the Netherlands (<0.1% 
of the population), the authors wondered if HCV is also 
associated with MC in their regional centers. To respond 
to this issue, 22 patients were tested with type II MC for 
HCV antibodies and HCV RNA and the results from these 
analyses were negative [14]. Other tests, such as RF activity 
and complement levels (C3 and C4), should be included in 
the testing panel to ensure better patient management and 
monitoring [15]. There is not enough data about cryoglob-
ulinemia in heroin addicts without hepatitis infection.
One of the aims of this study was to observe some hu-
moral immunologic indicators (immunoglobulins; com-
plement fractions C3, C4; rheumatoid factor; circulating 
immune complexes) and their possible association with 
the presence of cryoglobulins in heroin addicts. It is a 
known fact that changes in immunoglobulin fractions in 
heroin addicts might be an indicator for immunological 
impairment [3]. Decreased concentration especially of 
complement (C4) is accompanying biochemical parameter 
to cryoglobulinemia [14]. The presence of RF could serve 
as one of many serological markers of autoimmunity and 
is one of the main components of cryoglobulinemia [11]. 
High concentrations of RF are most frequently detected 
in patients with MC [13]. A group of 363 heroin addicts 
who were HbsAg negative, anti-HCV negative and HIV 
negative, in comparison with the group of 70 healthy sub-
jects, were examined for some humoral immune indica-
tors (immunoglobulins; complement fractions C3, C4; RF; 
CIC, cryoglobulins and other) and the following results 
were obtained: increased concentration of IgG, IgM, RF, 
CIC and decreased concentration of complement fraction 
C4 in heroin addicts. Seventy patients (19.3%) were with 
detectable cryoglobulins [16].
Table 1. Serum immunoglobulins IgA, IgG and IgM in the groups of 
cryoglobulin positive (CP), cryoglobulin negative (CN) heroin addicts 
and control group (CG)
Immunoglobulins Group N Mean±SD p
Ig A  
(0.7–4.0 g/l)
CP 70 2.54±1.05
0.07CN 70 2.29±1.08
CG 70 2.16±0.8
IgG  
(7.0–16.0 g/l)
CP 70 12.57±3.09
0.10CN 70 12.36±3.37
CG 70 11.55±2.38
IgM  
(0.4–2.3 g/l)
CP 70 1.65±0.85
0.11CN 70 1.85±1.03
CG 70 1.56±0.53
Table 2. Complement fractions (C3, C4) in the groups of cryoglobulin 
positive (CP), cryoglobulin negative (CN) heroin addicts and control 
group (CG)
Complement fractions Group N Mean±SD p
C3  
(0.8–1.4 g/l)
CP 70 1.17±0.30
0.16CN 70 1.10±0.17
CG 70 1.11±0.18
C4  
(0.2–0.5 g/l)
CP 70 0.23±0.09
0.10CN 70 0.36±0.63
CG 70 0.31±0.10
Table 3. Rheumatoid factor (RF) in the groups of cryoglobulin positive 
(CP), cryoglobulin negative (CN) heroin addicts
Parameter Group N Mean±SD p
RF 
(<13 IU/ml)
CP 70 10.75±4.42
0.0019
CN 70 8.43±4.22
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In this study the statistical analysis has shown no sig-
nificant difference for concentrations of IgA, IgG, IgM, 
complement fractions C3 and C4 and CICs between CP 
and CN heroin addicts without hepatitis infection. Statisti-
cal analyses showed that there was significant difference 
between CP and CN heroin addicts in the concentration 
of RF (p=0.0019).
In this study presence of cryoglobulins was more fre-
quently detected in intravenous heroin addicts and in ad-
dicts that reported longer periods of heroin abuse. The 
incidence of autoantibodies and the severity of clinical 
symptoms are related to the duration of heroin abuse [4]. 
This could explain why heroin addicts that reported longer 
history of heroin abuse had detectable cryoglobulins more 
often. Another explanation could be that individuals re-
petitively inject heroin which also contains a diluent. It 
is believed that heroin or its diluents are antigens or may 
become antigens forming complexes with endogenous 
proteins [3, 4].
Another aim of this study was to assess clinical manifes-
tations in CP heroin addicts. The objective of the French 
CryoVasc survey was to describe the baseline features in 
211 patients with non-hepatitis C virus CryoVas. Autoim-
mune disturbance was found in 73 patients (30%), B-cell 
lymphoma in 52 patients (21%) and essential cryoglob-
ulinemia in 117 patients (49%). In these patients most 
common clinical manifestations were purpura 75%, pe-
ripheral neuropathy 52%, glomerulonephritis 35%, Ray-
naud’s phenomenon 26%, arthralgia 44%, skin ulcers 16%, 
necrosis of the skin 14%, gastrointestinal disturbance 6%, 
changes in the central nervous system 2% and respira-
tory difficulties 2% [17, 18]. Data on clinical spectrum 
and therapeutic management of noninfectious MC vas-
culitis (CryoVas) in the era of hepatitis C virus screening 
are lacking [19]. Essential MC tended to be more severe 
than secondary disease with, in particular, more frequent 
renal and peripheral nerve involvement. The correlation 
between non-HCV-associated type II MC remains essen-
tial. More efforts should be given to finding etiological 
factors other than HCV [16, 20]. In this study statistical 
analysis has shown that clinical manifestations were more 
common in CP heroin addicts.
CONCLUSION
A comparison of CP and CN heroin addicts has shown 
no significant differences in concentrations of serum IgA, 
IgG, IgM, complement fractions C3 and C4, and CIC. 
There was significant difference in the concentration of 
RF between CP and CN heroin addicts. Clinical manifesta-
tions were more common in CP compared to CN heroin 
addicts, including arthralgias, Raynaud’s phenomenon, 
respiratory, neurologic, renal disorders and skin changes.
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КРАТАК САДРЖАЈ
Увод Кри о гло бу ли ни су за себ ни или ме шо ви ти иму но гло-
бу ли ни под ло жни ре верз ној пре ци пи та ци ји на ни ским тем-
пе ра ту ра ма.
Циљ ра да Ци ље ви овог ра да би ли су: 1) по ре ђе ње хе ро ин-
ских за ви сни ка по зи тив них на кри о гло бу лин (КП), за ви сни-
ка не га тив них на кри о гло бу лин (КН) и кон трол не гру пе (КГ) 
ис пи та ни ка у по гле ду се ру ма иму но гло бу ли на IgG, IgA, IgM 
и ком пле мент них ком по нен ти C3 и C4; 2) по ре ђе ње КП и КН 
хе ро ин ских за ви сни ка у по гле ду ре у ма то ид ног фак то ра (RF) 
и цир ку ли шу ћих имун ских ком плек са (CIC); 3) про це њи ва ње 
кли нич ких ма ни фе ста ци ја код КП хе ро ин ских за ви сни ка.
Ме то де ра да Ово је упо ред на сту ди ја бо ле сни ка ам бу лант-
но ле че них на Уни вер зи тет ској кли ни ци за ток си ко ло ги ју у 
Ско пљу то ком три и по го ди не, од ја ну а ра 2009. до ју на 2012. 
Ис пи та но је 140 хе ро ин ских за ви сни ка без HBsAg, се ро не га-
тив них на ин фек ци је са HCV и HIV. Ис пи та ни ци су свр ста ни 
у две гру пе: 70 КП и 70 КН хе ро ин ских за ви сни ка. Као из-
вор по да та ка о бо ле сни ци ма ко ри шћен је прет ход но са чи-
њен упит ник ко ји су бо ле сни ци са ми по пу ни ли. Код свих 
ис пи та ни ка ура ђе не су сле де ће ана ли зе: уреа и кре а ти нин 
у се ру му, кре а ти нин у мо кра ћи, про те и ну ри ја, 24-ча сов на 
про те и ну ри ја, IgM, IgG, IgA, C3, C4, RF, CIC, кли ренс кре а ти-
ни на, ЕКГ, ток си ко ло шка ана ли за узор ка мо кра ће на опи о де 
и кри о гло бу ли ни. Осим код ове две гру пе, IgG, IgA, IgM, C3 и 
C4 су ис пи та ни и код 70 здра вих ис пи та ни ка (КГ).
Ре зул та ти Сту ди ја је по ка за ла да не по сто ји ста ти стич ки 
зна чај на раз ли ка из ме ђу КП и КН хе ро ин ских за ви сни ка и КГ 
у по гле ду кон цен тра ци ја IgA, IgG, IgM, C3 и C4, ни ти из ме ђу 
КП и КН у по гле ду кон цен тра ци је CIC. По сто ја ла је, ме ђу тим, 
ста ти стич ки зна чај на раз ли ка из ме ђу КП и КН у по гле ду кон-
цен тра ци је RF. Сле де ћа ста ња су се знат но че шће ис по ља-
ва ла код КП не го код КН хе ро ин ских за ви сни ка: ар трал ги ја, 
Реј но ов фе но мен, ре спи ра тор не те шко ће, не у ро ло шки по-
ре ме ћа ји, ис по ље не про ме не на ко жи, хе ма ту ри ја, 24-ча сов-
ни ни вои про те и ну ри је и ума њен ре нал ни кли ренс.
За кљу чак Ни је би ло раз ли ка у кон цен тра ци ја ма IgG, IgA, 
IgM, C3, C4 и CIC, док је по сто ја ла раз ли ка у кон цен тра ци ји 
RF из ме ђу КП и КН хе ро ин ских за ви сни ка. Кли нич ке ма ни-
фе ста ци је (ар трал ги је, Реј но ов фе но мен, ре спи ра тор ни, не-
у ро ло шки и ре нал ни по ре ме ћа ји и про ме не на ко жи) би ле 
су че шће код КП хе ро ин ских за ви сни ка.
Кључ не ре чи: кри о гло бу лин; иму но гло бу ли ни; ком пле мент; 
ре у ма то ид ни фак тор; хе ро ин ски за ви сни ци не ин фи ци ра ни 
хе па ти ти сом
Постојање неких хуморалних имунских индикатора и клиничких 
манифестација код хероинских зависника позитивних на криоглобулин 
без доказа о инфекцији вирусом хепатитиса 
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